Victorian General Practitioners (GPs) are calling on patients to prioritize consultations with their regular doctors instead of seeking quick solutions from pharmacies. This plea follows a recent media campaign launched by the state’s Health Department promoting pharmacy prescribing, which has raised concerns among healthcare professionals regarding patient safety.
In a statement, Dr. Anita Muñoz, Chair of the Royal Australian College of GPs (RACGP) Victoria, emphasized the importance of receiving care from a GP familiar with a patient’s medical history. “Patient safety must come first,” she stated. Dr. Muñoz urged the public to consult with GPs for accurate diagnoses, stressing that no health condition can be considered “simple.”
The push for pharmacy prescribing allows pharmacists to dispense medications, including antibiotics, based on checklists and brief training courses. Dr. Muñoz warned that this approach cannot substitute for a proper medical diagnosis, which typically requires over a decade of training and extensive practical experience.
She highlighted significant risks associated with bypassing GP diagnoses, including incorrect treatment, missed serious illnesses, and rising antimicrobial resistance. “Removing the GP diagnosis presents significant risks to patient safety,” she noted. Reports from similar programs in Queensland and New South Wales have already shown instances of misdiagnosis and ineffective treatment. For example, a pilot report indicated that 13% of patients seeking treatment for urinary tract infection symptoms in Victoria did not experience resolution.
Concerns mount as the pharmacy lobby pushes for broader pharmacy prescribing practices across Australia, according to Dr. Muñoz. She expressed frustration over the perceived neglect of medical expertise and the suppression of debate surrounding these changes. “It is deeply concerning to see Victoria succumbing to this pressure,” she stated.
The RACGP Victoria Chair insisted that high-quality patient care must remain the priority. The community pharmacy program, she argued, compromises patient safety by enabling pharmacists to both prescribe and dispense medication. “This creates a fundamental conflict of interest,” she said.
Dr. Muñoz drew parallels with the telehealth sector, where prioritizing profit has led to errors and complications. “It is critical that these mistakes are not repeated in the rollout of pharmacy prescribing,” she cautioned. The RACGP plans to continue advocating for a healthcare model that prioritizes patient health and safety over expedient solutions.
Collaboration between GPs and pharmacists is essential, according to Dr. Muñoz. “GPs and pharmacists each bring vital expertise to the healthcare system,” she noted. She supports sensible initiatives, such as funding for practices to incorporate more pharmacists within a collaborative, GP-led multidisciplinary care approach.
The ongoing discussion highlights the need for a balanced approach to healthcare that safeguards patient welfare while utilizing the strengths of both GPs and pharmacists. As the debate unfolds, the RACGP remains committed to advocating for a system that prioritizes comprehensive patient care.
